What is the appropriate management of suspected ethylene glycol poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ethylene Glycol Intoxication

Immediately administer fomepizole (15 mg/kg loading dose) upon suspicion of ethylene glycol poisoning, and initiate hemodialysis if the patient presents with anion gap >27 mmol/L, glycolate >12 mmol/L, ethylene glycol concentration ≥50 mg/dL, coma, seizures, or acute kidney injury. 1

Immediate Antidote Therapy

Fomepizole is the preferred first-line antidote over ethanol due to more predictable alcohol dehydrogenase inhibition, absence of CNS depression, and simpler dosing without requiring continuous monitoring. 1

  • Loading dose: 15 mg/kg IV immediately upon suspicion 1
  • Maintenance dosing: Every 12 hours during standard therapy 2
  • During hemodialysis: Increase frequency to every 4 hours as fomepizole is dialyzable 1
  • Continue until: Ethylene glycol concentration <20 mg/dL, patient asymptomatic, pH normalized, and anion gap <18 mmol/L 1

If fomepizole is unavailable, ethanol can be used as an alternative ADH inhibitor, but requires intensive monitoring to maintain therapeutic levels of 100-150 mg/dL. 3, 1

  • Ethanol dosing during hemodialysis: Increase maintenance rate to 250-350 mg/kg/hour 1
  • Monitor ethanol levels: Every 2-4 hours during extracorporeal treatment 1
  • Critical caveat: Ethanol causes CNS depression, unpredictable ADH blockade, and treatment failures occur even with minimal acidosis, requiring lower thresholds for hemodialysis. 1

Indications for Hemodialysis

Intermittent hemodialysis is strongly recommended (not just suggested) when ANY of the following criteria are met: 4, 1

Strong Indications (Recommend Hemodialysis):

  • Anion gap >27 mmol/L 4, 1
  • Glycolate concentration >12 mmol/L 4, 1
  • Ethylene glycol concentration ≥50 mg/dL (≥50 mmol/L) 4, 1
  • Severe clinical features: Coma, seizures, or acute kidney injury (KDIGO stage 2 or 3) 4, 1

Conditional Indications (Suggest Hemodialysis):

  • Anion gap 23-27 mmol/L 4
  • Glycolate concentration 8-12 mmol/L 4
  • Osmol gap >50 (especially if using ethanol as antidote) 4, 1

Important distinction: If ethanol is used instead of fomepizole, the threshold for hemodialysis is LOWER because of unpredictable ADH blockade and higher risk of treatment failure. 1

Hemodialysis Technical Specifications

Intermittent hemodialysis is the preferred modality over continuous kidney replacement therapy (CKRT) because it removes ethylene glycol and metabolites faster and corrects acidemia more rapidly. 1

  • If intermittent hemodialysis unavailable: Use CKRT as second-line option 4, 1
  • Exception for CKRT: Consider if patient has marked brain edema 1

Cessation Criteria for Hemodialysis:

Stop hemodialysis when ALL of the following are achieved: 4, 1

  • Anion gap <18 mmol/L 4, 1
  • Ethylene glycol concentration <4 mmol/L (25 mg/dL) 4, 1
  • All acid-base abnormalities corrected 1

Supportive Care

  • Sodium bicarbonate: For severe metabolic acidosis 1
  • Thiamine and pyridoxine: As cofactors to enhance metabolism of toxic intermediates 1, 5
  • Mechanical ventilation: If respiratory failure develops 1
  • Vasopressors: For refractory hypotension 1

Critical Diagnostic Pitfalls to Avoid

Do not rely solely on reported ethylene glycol dose for treatment decisions because anion gap only predicts need for hemodialysis if high pre-test probability exists. 1

  • Measure both parent compound AND metabolites: Ethylene glycol concentrations diminish as toxic metabolites (glycolate, oxalate) accumulate, so both must guide treatment 1
  • Anion gap limitations: May overestimate or underestimate glycolate concentration 1
  • Suspect ethylene glycol in: Intoxicated patient with anion gap acidosis, hypocalcemia, urinary crystals (calcium oxalate monohydrate), and nontoxic blood alcohol concentration 6
  • Early neurological symptoms: Altered mental status, seizures, or coma may appear before significant acidosis develops 5

Special Considerations

Monitor for alcohol withdrawal in patients with alcohol use disorder, especially during hemodialysis when ethanol is being removed. 1, 5

Timing is critical: Initiating fomepizole before serum creatinine rises can minimize renal impairment, with metabolic acidosis resolving within 3 hours of therapy initiation. 6

Prognosis

  • Overall mortality: 18.7% across all cases 1
  • Mortality with glycolate ≤12 mmol/L or anion gap ≤28 mmol/L: 3.6% 4
  • Chronic kidney disease in survivors: 16.8%, with dialysis-dependent CKD in 2.9% 1
  • Higher mortality: Late presentations with glycolate >12 mmol/L or anion gap >28 mmol/L 1

References

Guideline

Ethylene Glycol Poisoning Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ethanol Dosing for Polyethylene Glycol Intoxication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ethoxydiglycol Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of ethylene glycol poisoning.

American family physician, 2002

Related Questions

What is the mechanism of ethylene glycol and pyridoxine (Vitamin B6) interaction?
What is the treatment for ethylene glycol (antifreeze) poisoning?
What is the mechanism of Fomepizole (4-methylpyrazole) in treating ethylene glycol poisoning?
What are the effects of Ethylene Glycol (EG) poisoning?
What are the effects of drinking antifreeze on the kidneys and can it cause kidney stones?
What are the recommended starting doses of tramadol (immediate‑release and extended‑release) for an opioid‑naïve adult, and how should they be adjusted in patients over 65 years or with renal/hepatic impairment?
What are the differential diagnoses and recommended treatment for white patches on the tongue?
My fasting plasma glucose is 105 mg/dL; does this indicate prediabetes and what management steps should I take?
What is the recommended dosing and administration of Linzess (linaclotide) for an adult with irritable bowel syndrome with constipation or chronic idiopathic constipation, and what are the major side effects and contraindications?
What hydrocortisone formulation and dose is appropriate for an 11‑month‑old infant?
How should I interpret and manage an asymptomatic patient whose echocardiogram shows normal left ventricular size with preserved systolic function (ejection fraction ≈ 65 %), diastolic dysfunction, mild concentric left ventricular hypertrophy, mild left and right atrial enlargement, a trileaflet aortic valve that is thickened with restricted motion and peak/mean gradients of 25 mmHg and 13 mmHg (mild aortic stenosis), mild mitral annular calcification with mild mitral regurgitation, mild tricuspid regurgitation, normal estimated pulmonary artery systolic pressure (29 mmHg), and no pericardial effusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.